Agenus Inc. (AGEN) 2008年年度报告「NASDAQ」.pdf

《Agenus Inc. (AGEN) 2008年年度报告「NASDAQ」.pdf》由会员分享，可在线阅读，更多相关《Agenus Inc. (AGEN) 2008年年度报告「NASDAQ」.pdf（154页珍藏版）》请在三个皮匠报告上搜索。

1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549Form 10-KANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIESEXCHANGE ACT OF 1934For the fiscal year ended December 31,2008orTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIESEXCHANGE ACT OF 1934For the tran

2、sition period fromtoCommission File Number:000-29089Antigenics Inc.(exact name of registrant as specified in its charter)Delaware06-1562417(State or other jurisdiction ofincorporation or organization)(I.R.S.EmployerIdentification No.)3 Forbes Road,Lexington,Massachusetts 02421(Address of principal e

3、xecutive offices,including zip code)Registrants telephone number,including area code:(781)674-4400Securities registered pursuant to Section 12(b)of the Act:Common Stock,$.01 Par ValueThe NASDAQ Global Market(Title of each class)(Name of each exchange on which registered)Securities registered pursuan

4、t to Section 12(g)of the Act:NoneIndicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the SecuritiesAct.Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d)of theAct.Yes No Indicate by ch

5、eck mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of theSecurities Exchange Act of 1934 during the preceding 12 months(or for such shorter period that the registrant was required to filesuch reports),and(2)has been subject to such filing requirements

6、for the past 90 days.Yes No Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein,andwill not be contained,to the best of registrants knowledge,in definitive proxy or information statements incorporated by referencein Part III of thi